NASDAQ · Biotechnology

NXTC (NXTC) Stock

$5.00 +17.81% NASDAQ: NXTC Healthcare

Valuation

MetricValue
Price$5.00
Market Cap$18.04M
P/E Ratio-0.26
P/B Ratio0.30
P/S Ratio0.00
EPS (TTM)$-8.76
52-Week High$15.74
52-Week Low$1.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-132.40%
ROA-66.71%
ROCE-165.71%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.18
Current Ratio4.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-71.0M$-76.0M$-68.0M$-60.0M$-58.0M
Net Profit$-69.0M$-75.0M$-63.0M$-56.0M$-56.0M
EPS$-30.15$-32.32$-27.04$-23.88$-19.65
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$242.0M$184.0M$128.0M$81.0M$50.0M
Total Liabilities$9.0M$17.0M$14.0M$15.0M$15.0M
Cash$12.0M$27.0M$13.0M$28.0M$26.0M
Borrowings$0$7.0M$7.0M$6.0M$5.0M

Latest News

Top Premarket Decliners MT Newswires · Jul 15, 2026 Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · Jul 14, 2026 Top Midday Gainers MT Newswires · Jul 14, 2026 Sector Update: Healthcare Stocks Fall Tuesday Afternoon MT Newswires · Jul 14, 2026 BC-Most Active Stocks Associated Press · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-57.0M$-54.0M$-53.0M$-41.0M$-50.0M
Investing Cash Flow$34.0M$66.0M$38.0M$55.0M$26.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-24.0M$14.0M$-14.0M$15.0M$-2.0M
Free Cash Flow$-60.0M$-56.0M$-54.0M$-41.0M$-50.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.34
FCF Yield-871.58%
Quick Ratio4.61
Interest Coverage—
Return 1Y39.29%
Return 3Y-68.61%
Return 5Y-92.36%

Ownership

Insiders Held14.80%
Institutions Held62.40%
Institutions Float Held73.24%
Institutional HolderSharesReport Date
Squadron Capital Management LLC265,0002026-03-31
Affinity Asset Advisors, Llc241,8262026-03-31
Ikarian Capital, LLC238,3032026-03-31
Sofinnova Investments, Inc.222,6542026-03-31
SilverArc Capital Management, LLC176,0572026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTX $4.93 +0.20% -4.76 $177.56M 0.00%
BOLD $2.48 -3.50% -0.56 $55.74M 0.00%
INTS $4.57 +2.70% -0.60 $12.35M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%
JSPR $0.63 +1.48% -0.21 $10.24M 0.00%

About NXTC

NXTC is led by CEO Michael S. Richman, employs 43 people, headquartered in US, publicly traded since 2019.

NXTC stock trades at $5.00 with a market capitalization of $18.04M. The stock is valued at a price-to-earnings (P/E) ratio of -0.26, price-to-book of 0.30, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.56 and $15.74, and currently trades 68.2% below its 52-week high.

On profitability, NXTC generates a return on equity (ROE) of -132.40%, return on capital employed of -165.71%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides